fbpx

REQUEST A CONSULTATION

Ready to contact us for a consultation about your condition and our medical services? The staff of our Global Patient Services is ready to help. Please select the appropriate button to get started.
search
News

New Sheba Research Shows Encouraging Results for Schizophrenia Treatment

Schizophrenia Research Shows Promising Results
A recent study led by Prof. Mark Weiser, Director of the Psychiatric Division at Sheba Medical Center , confirmed a suspected link between using estrogen patches and the reduction in symptoms experienced by women with schizophrenia. Schizophrenia can be a debilitating disorder, and the results of this research offer a rare ray of hope to patients worldwide.

Researchers applied estrogen patches to premenopausal women with schizophrenia over an eight-week period. Following this period, the women experienced fewer hallucinations and delusions. They also demonstrated improved social skills and a new sense of initiative.

Many previous studies that investigated the treatment of schizophrenia resulted in inconsistent findings, with positive outcomes that could not be replicated. Consequently, schizophrenia is largely misunderstood. Yet, this new Israeli study was able to replicate and confirm the results discovered by Dr. Jayashri Kulkarni, Professor of Psychiatry at The Alfred and Monash University in Australia. The link between estrogen patches and an improvement in schizophrenia symptoms in women has now been scientifically verified.

“This is a significant breakthrough in the study of schizophrenia,” said Prof. Weiser. “These latest findings are a promising step toward understanding schizophrenia in women, and Sheba Medical Center is honored to be a part of this discovery.”

The promising results support the continued study of the relationship between estrogen and schizophrenia and highlight the pressing need to develop new chemical compounds that bind estrogen receptors in the brain. Additionally, they shed light on the ways in which men and women are affected differently.

The study was funded by the Stanley Medical Research Institute, a non-profit organization based in Washington, DC, and conducted in the Republic of Moldova.

Related
Sheba and Mayo Clinic merge Data-Sharing Network
News May 18.
Sheba and Mayo Clinic Partner to Transform Patient Care Through an Innovative Data-Sharing Network
Sheba Medical Center has joined the Mayo Clinic Platform Connect, a global data-sharing network that aims to revolutionize healthcare. The groundbreaking platform provides a safe,…
Read More
Sheba Medical Center is working on enhancing patient safety with AI solutions.
News May 18.
Enhancing Patient Safety and Care with AI Solutions
With improving patient care a top priority, Sheba recognized technological innovation as an essential enabler of progress and transformation, with a particular emphasis on artificial…
Read More
IBD passport for patients with ulcerative colitis.
News May 17.
Meet the IBD Passport: A New Hope for Ulcerative Colitis and Crohn’s Disease Patients 
Ulcerative colitis (UC) and Crohn’s disease, the two most common forms of inflammatory bowel disease (IBD), can cause frustrating symptoms like diarrhea, abdominal pain, bloating,…
Read More